Financing
Ceregene was launched in January 2001. Our investors include Alta Partners, MPM Capital, Investor Growth Capital, and and BioSante Pharmaceuticals (Nasdaq: BPAX), as well as Hamilton BioVentures and California Technology Partners. We raised $10.5 million in our initial financing and $32 million in our Series B financing in 2004, led by Alta Partners and MPM Capital. In the first quarter of 2007, we raised an additional $28.1 million in our Series C financing, led by Investor Growth Capital. We closed our Series D financing, co-led by Hamilton BioVentures and Alta Partners, with participation from MPM Capital and Investor Growth Capital, in the last quarter of 2010 for $11.5 million. In addition, Ceregene has brought in approximately $40M in non-dilutive financing.
